Probably hoping in vain, we don't even know for sure if an SSRA will be done.  But if it is, wouldn't this be an outstanding audience to deliver the news in front of.  

Do it at some Bloom Burton or Bio Invest conference..."We've just completed a 'Sample Size Re-Estimation Analysis' and we're thrilled to announce that our Phase III BETonMACE trial is properly powered at 2,400 patients".  I can just picture the yawns and blank stares.  

And looking at the schedule it seems like a sweet time slot too....a break from 10:30 to 11 and then Dr Wong's 30 minute presentation followed by 15 minutes for discussion.  

Even without a SSRA, this does look good...thanks for keeping us up to date BDZ